Cargando…
Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk
Glatiramer acetate is used therapeutically in multiple sclerosis but also known for adverse effects including elevated coronary artery disease (CAD) risk. The mechanisms underlying the cardiovascular side effects of the medication are unclear. Here, we made use of the chromosomal variation in the ge...
Autores principales: | Brænne, Ingrid, Zeng, Lingyao, Willenborg, Christina, Tragante, Vinicius, Kessler, Thorsten, Willer, Cristen J., Laakso, Markku, Wallentin, Lars, Franks, Paul W., Salomaa, Veikko, Dehghan, Abbas, Meitinger, Thomas, Samani, Nilesh J., Asselbergs, Folkert W., Erdmann, Jeanette, Schunkert, Heribert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567477/ https://www.ncbi.nlm.nih.gov/pubmed/28829817 http://dx.doi.org/10.1371/journal.pone.0182999 |
Ejemplares similares
-
A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors
por: Brænne, Ingrid, et al.
Publicado: (2017) -
Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets
por: Lempiäinen, Harri, et al.
Publicado: (2018) -
Utilization of Mental Health Care, Treatment Patterns, and Course of Psychosocial Functioning in Northern German Coronary Artery Disease Patients with Depressive and/or Anxiety Disorders
por: Westermair, Anna Lisa, et al.
Publicado: (2018) -
Mental Health and Psychosocial Functioning Over the Lifespan of German Patients Undergoing Cardiac Catheterization for Coronary Artery Disease
por: Schaich, Anja, et al.
Publicado: (2018) -
Genetic and modifiable risk factors combine multiplicatively in common disease
por: Pang, Shichao, et al.
Publicado: (2022)